Stocksigma LogoStocksigma Logo

Beta Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Beta Drugs Ltd. announced that its Board of Directors will meet on 22nd Oct'26 to consider and approve the unaudited standalone and consolidated financial

Beta Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Beta Drugs Ltd 路 Intimation 路 22 Oct 2026, 5:30 am

Beta Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results Beta Drugs Ltd. announced that its Board of Directors will meet on 22nd Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for designated persons and their immediate relatives has been closed effective 1st Oct'26 and will remain closed until 24th Oct'26, 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Beta Drugs Ltd

All Beta Drugs Ltd announcements